The prognostic importance of proliferative activity and oestrogen receptor expression in stage I endometrial carcinomas

Journal of Obstetrics and Gynaecology

Volumn 26, Issue 8, 2006, Pages 798-801

  Zergeroglu S ^a,b   Ozdemir H B ^a   Ozel M ^a   Kuzey, G M ^a   Mollamahmutoglu L ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY KI 67;

ABDOMINAL HYSTERECTOMY; ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CELL PROLIFERATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERNATIONAL FEDERATION OF GYNECOLOGY AND OBSTETRICS; MEDICAL SOCIETY; MENOPAUSE; MYOMETRIUM; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; SALPINGOOOPHORECTOMY; STATISTICAL ANALYSIS; TUMOR VASCULARIZATION; TUMOR VOLUME;

ADENOCARCINOMA; CELL PROLIFERATION; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PROGNOSIS; RECEPTORS, ESTROGEN;

EID: 33845347423     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.1080/01443610600984669     Document Type: Article

References (26)

1. Athanassiadou P, Petrakakou E, Liossi A, Nakapoulou L, Zerva C, Dimopoulos A. 1999. Prognostic significance of p53, bcl-2 and EGFR in carcinoma of the endometrium. Acta Cytologica 43:1039-1044.
2. Bokhman JV. 1983. Two pathogenetic types of endometrial carcinoma. Gynecologic Oncology 15:10-17.
3. Borazjani G, Twiggs JB, Leung BS, Prem KA, Adcock LL, Carson LF. 1989. Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma. American Journal of Obstetrics and Gynecology 161:1253-1257.
4. Cattoretti G, Pileri S, Parravicini C, Becker MHG, Poggi S, Bifulco C et al. 1993. Antigen unmasking on formalin fixed paraffin embedded tissue sections. Journal of Pathology 171:83-98.
5. Creasman WT, Soper JT, McCarty KS Jr, McCarty KS Sr, Hinshaw W, Clark-Pearson DL. 1985. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. American Journal of Obstetrics and Gynecology 151:922-932.
6. Ehrlich CE, Young PCM, Stehman FB, Sutton GP, Alford WM. 1988. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium. American Journal of Obstetrics and Gynecology 158:796-807.
7. Fakuda K, Mori M, Uchiyama M, Iwai K, İvasaca T, Sugimori H. 1998. Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecologic Oncology 69:220-225.
8. Gal D, Recio FO, Zamurovic D, Tancer ML. 1991. Lymphvascular space involvement: A prognostic indicator in endometrial adenocarcinoma. Gynecologic Oncology 42:142-145.
9. Gehring PA, Le L Van, Olatidoye B, Geradts J. 1999. Oestrogen receptor status, determined by immunohistochemistry, as a predictor of the recurrence of stage I endometrial carcinoma. Cancer 86:2083-2089.
10. Geisinger KR, Homesley HD, Morgan TM, Kute TE, Marshall RB. 1986. Endometrial adenocarcinoma (a multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors). Cancer 58:1518-1525.
11. Hachisuga T, Kaku T, Fukuda K, Eguchi F, Emoto M, Kamura T et al. 1999. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer 86:2090-2097.
12. Kottmeier HL. 1979. Annual report on the results of treatment in gynecologic cancer. Vol 17. Stockholm, Sweden: International Federation of Gynecology and Obstetrics.
13. Kurman RJ, Zaino RJ, Norris HJ. 1994. Endometrial carcinoma. In: Kurman RJ, editor. Blaustein's pathology of female genital tract. 4th ed. New York: Springer. pp 439-486.
14. Lax SF, Pizer ES, Ronnett BM, Kurman RJ. 1998. Comparison of oestrogen and progesterone receptor Ki-67 and p53 immunoreactivity in uterine endometrioid carcinoma with squamous, mucinous, secretory and ciliated cell differentiation. Human Pathology 29:924-931.
15. Marrett LD, Meigs JW, Flannery JT. 1982. Trends in the incidence of cancer of the corpus uteri in Connecticut 1964-1979, in relation to consumption of exogenous oestrogens. American Journal of Epidemiology 116:57-67.
16. Mittal KR, Schwartz PE, Barwick KW. 1988. Architectural (FIGO) grading and other prognostic indicators in stage I endometrial adenocarcinoma with identification of high risk and low risk groups. Cancer 61:538-545.
17. Morris PC, Anderson JR, Anderson B, Buller RE. 1995. Steroid hormone receptor content and lymph node status in endometrial cancer. Gynecologic Oncology 56:406-411.
18. Nielson AL, Nyholm HJC. 1993. Proliferative activity as revealed by Ki-67, p53 in uterine adenocarcinoma of endometrioid type: Comparison of tumours from patients with and without previous oestrogen therapy. Journal of Pathology 171:199-205.
19. Pichon MF, Broet P, Magdelanat H, Delarue JC, Spyratos F, Basuvau JP et al. 1996. Prognostic value of steroid receptors after long term follow-up of 2257 operable breast cancers. British Journal of Cancer 73:1545-1551.
20. Salveson HB, Ýversen OE, Aksien LA. 1999. Prognostic significance of angiogenesis and Ki-67, p53 and p21 expression: A population based endometrial carcinoma study. Journal of Clinical Oncology 17:382-390.
21. Sasaki K, Murakami T, Takahashi M. 1987. The cell cycle associated change of the Ki-67 reactive nuclear antigen expression. Journal of Cell Physiology 133:579-584.
22. Sherman ME, Bur ME, Kurman RJ. 1995. p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorogenesis. Human Pathology 26:1268-1274.
23. Silverberg E, Lubera J. 1989. Cancer statistics. Cancer 39.
24. Takama F, Kanuma T, Wang D, Kagami I, Mizunuma H. 2001. Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer. British Journal of Cancer 84:545-549.
25. Yamauchi N, Sakamato A, Uozaki H, Lihara K, Machinami R. 1996. Immunohistochemical analysis of endometrial adenocarcinoma for bcl-2 and p53 in relation to expression of sex steroid receptor and proliferative activity. International Journal of Gynecological Pathology 15:202-208.
26. Zaino RJ, Kurman RJ, Diana KL, Morrow CP. 1995. The utility of the revised International Federation of Gynecology and Obstetrics histologic grading of endometrial adenocarcinoma using a defined nuclear grading system. A Gynecologic Oncology Group Study Cancer 75:81-86.